More than 30 malaria vaccine candidates are at various stages of development. The RTS,S vaccine is at the most advanced stage.
The World Health Organisation has recommended the introduction of the vaccine in Ghana, Kenya and Malawi as a pilot programme to assess its suitability in expanded immunisation programmes.
The vaccine could prove to be a powerful tool in sustaining the gains made in the last decade in reducing malaria related cases and deaths. Between 2000 and 2015, new malaria cases fell by 37% globally, and by 42% in Africa.

)